ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 168 filers reported holding ASCENDIS PHARMA A/S in Q1 2023. The put-call ratio across all filers is 0.19 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $1,522,106 | +15.0% | 12,085 | -14.5% | 0.29% | +3.5% |
| Q3 2023 | $1,323,601 | +23.1% | 14,135 | +17.4% | 0.28% | +31.6% |
| Q2 2023 | $1,074,838 | -17.8% | 12,043 | -1.3% | 0.22% | -43.0% |
| Q1 2023 | $1,308,191 | -18.9% | 12,201 | -7.6% | 0.38% | -75.9% |
| Q4 2022 | $1,613,337 | +15.8% | 13,210 | -2.1% | 1.56% | +22.4% |
| Q3 2022 | $1,393,000 | 0.0% | 13,495 | -10.0% | 1.28% | +20.7% |
| Q2 2022 | $1,393,000 | -21.0% | 14,987 | -0.3% | 1.06% | +27.6% |
| Q1 2022 | $1,764,000 | -23.8% | 15,027 | -12.7% | 0.83% | -1.4% |
| Q4 2021 | $2,316,000 | – | 17,216 | – | 0.84% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 11,225,357 | $1,001,863,112 | 18.92% |
| Q Global Advisors, LLC | 195,000 | $17,404 | 12.55% |
| Sofinnova Investments, Inc. | 754,032 | $67,297,356 | 4.41% |
| Avoro Capital Advisors LLC | 3,580,555 | $319,564,534 | 4.34% |
| Finepoint Capital LP | 139,772 | $12,474,651 | 4.32% |
| Spyglass Capital Management LLC | 657,853 | $58,713,380 | 4.24% |
| Saturn V Capital Management LP | 78,442 | $7,000,948 | 3.88% |
| DAFNA Capital Management LLC | 135,212 | $12,067,671 | 3.30% |
| ARS Investment Partners, LLC | 289,860 | $25,870,005 | 3.02% |
| Ghost Tree Capital, LLC | 100,000 | $8,925,000 | 2.95% |